NIOX Group PLC
82C
Company Profile
Business description
NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.
Contact
1 Robert Robinson Avenue
The Magdalen Centre
The Oxford Science Park
OxfordOX4 4GA
GBRT: +44 3303309356
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
84
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,820.30 | 6.40 | -0.07% |
CAC 40 | 7,902.25 | 23.79 | 0.30% |
DAX 40 | 24,456.81 | 92.75 | -0.38% |
Dow JONES (US) | 44,650.64 | 192.34 | 0.43% |
FTSE 100 | 8,975.66 | 108.64 | 1.23% |
HKSE | 24,437.14 | 408.77 | 1.70% |
NASDAQ | 20,630.66 | 19.33 | 0.09% |
Nikkei 225 | 39,587.87 | 58.49 | -0.15% |
NZX 50 Index | 12,686.68 | 73.52 | -0.58% |
S&P 500 | 6,280.46 | 17.20 | 0.27% |
S&P/ASX 200 | 8,580.10 | 9.10 | -0.11% |
SSE Composite Index | 3,528.68 | 18.99 | 0.54% |